---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-000993"
form_type: "8-K"
ticker: "PIII"
cik: "0001832511"
company_name: "P3 Health Partners Inc."
filed_at: "2024-01-10T23:59:59+00:00"
generated_at: "2026-06-07T01:02:29.716463+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# P3 Health reaffirms 2023 guidance; 2024 revenue $1.45B-$1.55B, positive EBITDA $20M-$40M

## Summary
- FY2023 reaffirmed: revenue $1.2B-$1.25B, medical margin $155M-$175M, Adj. EBITDA loss $30M-$50M.
- FY2024 guidance: revenue $1.45B-$1.55B, medical margin $230M-$250M, Adj. EBITDA positive $20M-$40M.
- Medicare Advantage members expected 125k-135k in 2024, up from 115k-120k in 2023.
- Medical margin PMPM guided $165-$175 in 2024, up from $120-$130 in 2023.
- Management expects meaningful profitability in 2024, citing robust pipeline and managed cost trend.

## SEC filing metadata
- accession: 0001628280-24-000993
- form_type: 8-K
- ticker: PIII
- cik: 0001832511
- company_name: P3 Health Partners Inc.
- filed_at: 2024-01-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832511/000162828024000993/0001628280-24-000993-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832511/000162828024000993/piii-20240109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-000993
- JSON: https://secwatch.observer/filing/0001628280-24-000993.json
- Plain text: https://secwatch.observer/filing/0001628280-24-000993.txt

## Key facts
- Earnings Releases
  P3 Health Partners Inc. reported Full-Year 2024 results: revenue $1.45 billion to $1.55 billion. Guidance initiated.
  - Period: Full-Year 2024
  - Revenue: $1.45 billion to $1.55 billion
  - Guidance: initiated
  - Result: guidance update
  source text: Providing full-year 2024 guidance: • Medicare Advantage Members from 125,000 to 135,000 • Revenue from $1.45 billion to $1.55 billion • Medical Margin from $230 million to $250 million • Medical Margin PMPM from $165 to $175 • Adjusted EBITDA from $20 million to $40 million, as previously announced
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832511/000162828024000993/0001628280-24-000993-index.htm
- Earnings Releases
  P3 Health Partners Inc. reported Full-Year 2023 results: revenue $1.2 billion to $1.25 billion. Guidance reaffirmed.
  - Period: Full-Year 2023
  - Revenue: $1.2 billion to $1.25 billion
  - Guidance: reaffirmed
  - Result: guidance update
  source text: Reaffirming full-year 2023 guidance : • Medicare Advantage Members from 115,000 to 120,000 • Revenue from $1.2 billion to $1.25 billion • Medical Margin from $155 million to $175 million • Medical Margin PMPM from $120 to $130 • Adjusted EBITDA is expected to be a loss between $50 million and $30 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832511/000162828024000993/0001628280-24-000993-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.